George Spencer-Green

George Spencer-Green

Hoofd Techniek/Wetenschap/O&O bij TAIWAN LIPOSOME COMPANY, LTD.
79 jaar
Consumer Services
Health Technology

Profiel

George Spencer-Green currently works at Taiwan Liposome Co., Ltd., as Chief Medical Officer from 2019.
Dr. Spencer-Green also formerly worked at Abbott Laboratories, as Global Medical Director from 2002 to 2005, Immunex Corp., as Franchise Medical Director from 1998 to 2002, Vertex Pharmaceuticals, Inc., as Senior Medical Director from 2007 to 2011, the University of Washington Medical Center, as Associate Professor, Dartmouth Medical School, as Associate Professor, the University of Cincinnati Medical Center, as Associate Professor, and Pfizer Ltd. (Taiwan), as Vice President from 2012 to 2015.
Dr. Spencer-Green received his undergraduate degree from Oberlin College, graduate degree from Dartmouth College, and doctorate degree from Columbia University College of Physicians & Surgeons.

Actieve functies van George Spencer-Green

BedrijvenFunctieBegin
TAIWAN LIPOSOME COMPANY, LTD. Hoofd Techniek/Wetenschap/O&O 01-02-2019

Eerdere bekende functies van George Spencer-Green

BedrijvenFunctieEinde
Corporate Officer/Principal 01-01-2015
VERTEX PHARMACEUTICALS INCORPORATED Hoofd Techniek/Wetenschap/O&O 01-01-2011
ABBOTT LABORATORIES Hoofd Techniek/Wetenschap/O&O 01-01-2005
Corporate Officer/Principal 01-01-2002
Corporate Officer/Principal -
Ervaring van George Spencer-Green in detail bekijken

Opleiding van George Spencer-Green

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

76

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit11

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Consumer Services

Consumer Services

Consumer Services

  1. Beurs
  2. Insiders
  3. George Spencer-Green
DE LAATSTE UREN | -40 %: De beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU